Quinidine Sulfate Extended-Release Tablets
» Quinidine Sulfate Extended-Release Tablets contain amounts of quinidine sulfate and dihydroquinidine sulfate totaling not less than 90.0 percent and not more than 110.0 percent of the labeled amount of quinidine sulfate, calculated as (C20H24N2O2)2·H2SO4·2H2O.
Packaging and storage— Preserve in well-closed, light-resistant containers.
Labeling— The labeling indicates the Dissolution Test with which the product complies.
Identification—
A: Shake a quantity of powdered Tablets, equivalent to about 50 mg of quinidine sulfate, with 100 mL of dilute sulfuric acid (1 in 350), and filter: the filtrate so obtained exhibits a vivid blue fluorescence. On the addition of a few drops of hydrochloric acid, the fluorescence disappears.
B: In the test for Chromatographic purity, the RF value of the principal spot obtained from the Test preparation corresponds to that from the Standard preparation.
C: Shake a quantity of the powdered Tablets, equivalent to about 100 mg of quinidine sulfate, with 10 mL of dilute hydrochloric acid (1 in 100), and filter: the filtrate so obtained meets the requirements of the tests for Sulfate 191.
Dissolution 711
test 1— If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 1.
Medium: 0.1 N hydrochloric acid; 900 mL.
Apparatus 1: 100 rpm.
Times: 1, 4, and 12 hours.
Procedure— Using filtered portions of the solution under test, diluted with 0.1 N hydrochloric acid if necessary, determine the amount of (C20H24N2O2)2·H2SO4·2H2O dissolved from UV absorbances at the wavelength of maximum absorbance at about 248 nm by comparison with a Standard solution having a known concentration of USP Quinidine Sulfate RS in the same Medium.
Tolerances— The percentages of the labeled amount of (C20H24N2O2)2·H2SO4·2H2O dissolved at the times specified conform to Acceptance Table 2.
Time (hours) Amount dissolved
1 between 20% and 50%
4 between 43% and 73%
12 not less than 70%
test 2— If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: 0.1 N hydrochloric acid; 900 mL.
Apparatus 1: 100 rpm.
Times: 1, 4, and 12 hours.
Procedure— Proceed as directed for Test 1.
Tolerances— The percentages of the labeled amount of (C20H24N2O2)2·H2SO4·2H2O dissolved at the times specified conform to Acceptance Table 2.
Time (hours) Amount dissolved
1 between 10% and 35%
4 between 30% and 55%
12 not less than 75%
Uniformity of dosage units 905: meet the requirements.
Procedure for content uniformity— Proceed as directed for Procedure for content uniformity in the test for Uniformity of dosage units under Quinidine Sulfate Capsules, using 1 powdered Tablet instead of the contents of 1 Capsule.
Chromatographic purity— Shake a quantity of powdered Tablets, equivalent to about 150 mg of quinidine sulfate, with 25 mL of diluted alcohol for 10 minutes, and filter. Using the filtrate as the Test preparation, proceed as directed in the test for Chromatographic purity under Quinidine Sulfate.
Assay— Proceed as directed in the Assay under Quinidine Sulfate Capsules, using powdered Tablets.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Sujatha Ramakrishna, Ph.D.
Scientist
1-301-816-8349
(MDCV05) Monograph Development-Cardiovascular
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106
(BPC05) Biopharmaceutics05
USP32–NF27 Page 3466
Pharmacopeial Forum: Volume No. 31(1) Page 184
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.